These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 11447769

  • 1. Fibromyalgia treatment with intravenous tropisetron administration.
    Stratz T, Färber L, Varga B, Baumgartner C, Haus U, Müller W.
    Drugs Exp Clin Res; 2001; 27(3):113-8. PubMed ID: 11447769
    [Abstract] [Full Text] [Related]

  • 2. Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients.
    Färber L, Stratz TH, Brückle W, Späth M, Pongratz D, Lautenschläger J, Kötter I, Zöller B, Peter HH, Neeck G, Welzel D, Müller W, German Fibromyalgia Study Group.
    Int J Clin Pharmacol Res; 2001; 21(1):1-13. PubMed ID: 11708570
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Do cytochrome enzymes influence the therapeutic effect of tropisetron in fibromyalgia?
    Stratz T, Kees F, Müller W.
    Drugs Exp Clin Res; 2003; 29(2):91-4. PubMed ID: 12951840
    [Abstract] [Full Text] [Related]

  • 6. The 5-HT3 blockers in the treatment of the primary fibromyalgia syndrome: a 10-day open study with Tropisetron at a low dose.
    Samborski W, Stratz T, Lacki JK, Klama K, Mennet P, Müller W.
    Mater Med Pol; 1996; 28(1):17-9. PubMed ID: 9088121
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ, Myers RR.
    Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
    [Abstract] [Full Text] [Related]

  • 8. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
    Gür A, Karakoc M, Nas K, Cevik R, Sarac J, Ataoglu S.
    Rheumatol Int; 2002 Sep; 22(5):188-93. PubMed ID: 12215864
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Results of the intravenous administration of tropisetron in fibromyalgia patients.
    Müller W, Stratz T.
    Scand J Rheumatol Suppl; 2000 Sep; 113():59-62. PubMed ID: 11028834
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study.
    Hrycaj P, Stratz T, Mennet P, Müller W.
    J Rheumatol; 1996 Aug; 23(8):1418-23. PubMed ID: 8856622
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of unilateral repetitive transcranial magnetic stimulation of the motor cortex on chronic widespread pain in fibromyalgia.
    Passard A, Attal N, Benadhira R, Brasseur L, Saba G, Sichere P, Perrot S, Januel D, Bouhassira D.
    Brain; 2007 Oct; 130(Pt 10):2661-70. PubMed ID: 17872930
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.